Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Free-floating long-term vascularized mesenchymal organoids.

iScience·2026
Same author

iMer, a naturally occurring MERTK splice variant, binds to GAS6 to decrease platelet activation and thrombus formation.

Blood vessels, thrombosis & hemostasis·2025
Same author

Prospects of current AXL-targeting therapies in early phase cancer trials.

Expert opinion on investigational drugs·2025
Same author

Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas.

Nature communications·2025
Same author

Discovery of Novel TYRO3/MERTK Dual Inhibitors.

Journal of medicinal chemistry·2025
Same author

Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitors.

European journal of medicinal chemistry·2025

相关实验视频

Updated: Jun 19, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.8K

作为一种向的新型癌症治疗方法的MERTK抑制.

K M Tanim1,2, Alisha Holtzhausen3, Aashis Thapa1,2

  • 1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.

International journal of molecular sciences
|July 27, 2024
PubMed
概括

本综述强调了TYRO3,AXL和MERTK (TAM) 受体氨酸激酶的30年之旅. 了解它们在癌症和自身免疫系统中的作用正在进步,为新疗法铺平了道路.

关键词:
这就是MERTK的意思.MERTK 抑制剂的使用这就是TAMAMTAM.接收器氨酸激酶受体有针对性的癌症治疗.

更多相关视频

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

相关实验视频

Last Updated: Jun 19, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.8K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

科学领域:

  • 分子生物学分子生物学
  • 生物化学 生物化学
  • 免疫学 免疫学 免疫学

背景情况:

  • 受体氨酸激酶 (RTK) 的TYRO3,AXL和MERTK (TAM) 家族被发现为具有未知功能的孤儿RTK.
  • 它们在生理学和病理生理学中的作用在过去十年中变得更加清晰.
  • 通过外部化酸丁氨酸 (PtdSer) 激活配体,将TAM RTK与多种过程联系起来.

研究的目的:

  • 审查MERTK (c-mer) 的发现,信号和临床潜力.
  • 通过埃尔普和格雷厄姆实验室的合作,突出30年来了解TAM RTK家族功能的进展.
  • 为未来的研究和治疗干预奠定基础.

主要方法:

  • 审查科学文献和研究结果.
  • 专注于厄普和格雷厄姆实验室的合作工作.
  • 对TAM RTK研究历史进展的分析.

主要成果:

  • 包括MERTK在内的TAM RTK参与至关重要的生物过程.
  • 外部化脂素 (PtdSer) 是TAM RTKs的一个关键激活剂.
  • 这些激酶在神经发育,癌症和自身免疫系统中发挥作用.

结论:

  • 在TAM RTK领域取得了显著的进步,超越了孤儿状态.
  • 对TAM RTK信号的进一步研究对于治疗开发至关重要.
  • 了解MERTK和相关激酶为治疗各种疾病提供了潜力.